Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

5-hydroxytryptamine 3 receptor antagonist

(5-hy-DROK-see-TRIP-tuh-meen 3 reh-SEP-ter an-TA-guh-nist)

A type of drug used to treat certain types of irritable bowel syndrome and relieve nausea and vomiting. It is a type of antiemetic. Also called 5-HT3 receptor antagonist and type 3 serotonin receptor antagonist.

5-hydroxytryptamine 3 receptor antagonist

Search NCI's Dictionary of Cancer Terms